Back to Search
Start Over
The challenge of peripheral arterial disease: How do we improve outcome?
- Source :
-
Atherosclerosis [Atherosclerosis] 2018 Mar; Vol. 270, pp. 196-198. Date of Electronic Publication: 2018 Jan 05. - Publication Year :
- 2018
- Subjects :
- Antibodies, Monoclonal adverse effects
Antibodies, Monoclonal, Humanized
Biomarkers blood
Drug Therapy, Combination
Dyslipidemias blood
Dyslipidemias diagnosis
Dyslipidemias mortality
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors adverse effects
Lipids blood
Peripheral Arterial Disease blood
Peripheral Arterial Disease diagnosis
Peripheral Arterial Disease drug therapy
Peripheral Arterial Disease mortality
Risk Factors
Serine Proteinase Inhibitors adverse effects
Treatment Outcome
Antibodies, Monoclonal therapeutic use
Dyslipidemias drug therapy
Hydroxymethylglutaryl-CoA Reductase Inhibitors therapeutic use
Serine Proteinase Inhibitors therapeutic use
Subjects
Details
- Language :
- English
- ISSN :
- 1879-1484
- Volume :
- 270
- Database :
- MEDLINE
- Journal :
- Atherosclerosis
- Publication Type :
- Academic Journal
- Accession number :
- 29395100
- Full Text :
- https://doi.org/10.1016/j.atherosclerosis.2017.12.031